BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 217 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,644,000 | -41.0% | 30,716 | -43.1% | 0.00% | -33.3% |
| Q2 2022 | $7,867,000 | -63.9% | 53,994 | -70.6% | 0.00% | -57.1% |
| Q1 2022 | $21,809,000 | +59.0% | 183,940 | +84.8% | 0.01% | +40.0% |
| Q4 2021 | $13,717,000 | -39.3% | 99,537 | -38.8% | 0.01% | -28.6% |
| Q3 2021 | $22,598,000 | +109.2% | 162,678 | +46.2% | 0.01% | +75.0% |
| Q2 2021 | $10,802,000 | +553.9% | 111,260 | +360.6% | 0.00% | – |
| Q1 2021 | $1,652,000 | -87.6% | 24,155 | -84.4% | 0.00% | -100.0% |
| Q4 2020 | $13,278,000 | +462.9% | 154,911 | +327.1% | 0.01% | +600.0% |
| Q3 2020 | $2,359,000 | -77.5% | 36,272 | -74.7% | 0.00% | -87.5% |
| Q2 2020 | $10,475,000 | +198.5% | 143,280 | +39.0% | 0.01% | +166.7% |
| Q1 2020 | $3,509,000 | +155.0% | 103,109 | +308.0% | 0.00% | +50.0% |
| Q4 2019 | $1,376,000 | -24.9% | 25,272 | -42.5% | 0.00% | -33.3% |
| Q3 2019 | $1,833,000 | +85.2% | 43,934 | +94.4% | 0.00% | +50.0% |
| Q2 2019 | $990,000 | +85.7% | 22,604 | +59.3% | 0.00% | +100.0% |
| Q3 2018 | $533,000 | -20.1% | 14,189 | -16.0% | 0.00% | -50.0% |
| Q2 2018 | $667,000 | +107.1% | 16,884 | +34.9% | 0.00% | +100.0% |
| Q1 2018 | $322,000 | – | 12,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |